|
NCRNA00183 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.051700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.564000E-01 |
| Normal-vs-Stage2 |
5.908600E-01 |
| Normal-vs-Stage3 |
1.182510E-03 |
| Normal-vs-Stage4 |
5.79829999999282E-05 |
| Stage1-vs-Stage2 |
6.276400E-01 |
| Stage1-vs-Stage3 |
2.941400E-03 |
| Stage1-vs-Stage4 |
6.015800E-04 |
| Stage2-vs-Stage3 |
1.021620E-02 |
| Stage2-vs-Stage4 |
6.048800E-04 |
| Stage3-vs-Stage4 |
2.627400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.548100E-02 |
| Normal-vs-AfricanAmerican |
1.885400E-01 |
| Normal-vs-Asian |
6.696800E-01 |
| Caucasian-vs-AfricanAmerican |
8.705400E-01 |
| Caucasian-vs-Asian |
1.064550E-01 |
| AfricanAmerican-vs-Asian |
3.509800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.20521387209283E-13 |
| Normal-vs-Female |
8.849600E-01 |
| Male-vs-Female |
1.11022302462516E-16 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.478400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.176500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.819830E-03 |
| Normal-vs-Age(81-100Yrs) |
1.040370E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.573000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.200470E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.903700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.126300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.204000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.940400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.790600E-04 |
| Classical-VS-Follicular |
4.290500E-02 |
| Classical-VS-Other |
6.924800E-01 |
| Classical-VS-Normal |
4.917600E-02 |
| Tall-VS-Follicular |
1.54907999999621E-05 |
| Tall-VS-Other |
1.770980E-01 |
| Tall-VS-Normal |
3.85219999999853E-05 |
| Follicular-VS-Other |
3.293800E-01 |
| Follicular-VS-Normal |
9.434200E-01 |
| Other-VS-Normal |
2.203400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.480990E-01 |
| Normal-vs-N1 |
2.040400E-01 |
| N0-vs-N1 |
9.813800E-01 |
|
|
